PCRF have awarded a total of £1.2million to ambitious projects tackling the UK’s deadliest cancer. It is the second year that they have invested over £1million in a single funding round, enabling innovative research that could lead to new treatments for this aggressive and complex disease.
Dr Bruce’s work focuses on pancreatic cancer cells and the unique way that they extract energy from the nutrients which help them to survive and grow. The cancer cells use this energy source to pump calcium out of the cell. As high levels of calcium can be fatal to such cells, Dr Bruce’s project will aim to utilise new drugs and cut off the supply of energy to the calcium pumps. This would kill cancer cells whilst leaving healthy ones unharmed. Maggie Blanks, PCRF’s founder and CEO, said:
“This is an amazing achievement, and it is thanks to the tireless fundraising of our supporters around the country who know that funding research is the only way to accelerate the development of new treatments and diagnostic tools that will improve patients’ chances of survival.”